Recall of Walgreens Saline Nasal Spray
Walgreens has announced the recall of over 41,000 bottles of saline nasal spray containing xylitol after the discovery of bacterial contamination. This product recall is significant as it affects consumers who purchased the nasal spray from Walgreens stores nationwide within the last year. The recall was officially documented on November 12, 2025, as reported to the FDA.
Reason for the Recall
The trigger for this extensive recall was the detection of Pseudomonas lactis, a bacterial entity categorized as a non-sterile contaminant according to regulatory standards. As a result, the FDA classified this recall as a Class II recall. This classification suggests that exposure to the contaminated product could potentially lead to temporary or medically reversible adverse health effects.
Such occurrences of contamination are a pressing concern for health authorities, manufacturers, and distributors, leading to tightened controls surrounding over-the-counter medical products. The FDA’s emphasis on vigilance in preventing microbial infections from non-sterile products cannot be overstated.
Details of the Affected Product
The Walgreens Saline Nasal Spray with xylitol is packaged in 45 ml (1.5 oz) bottles. It can be identified by its unique NDC code 0363-3114-01. According to FDA records, the affected batches carry the lot numbers 71409 (expiration February 28, 2027) and 71861 (expiration August 31, 2027), with a total of 41,328 bottles impacted by this recall.
Health Implications
The presence of Pseudomonas lactis in non-sterile medical products has been associated with health issues, especially mild respiratory tract infections. However, the FDA suggests that the risk of severe health consequences is relatively low given the Class II classification. Affected products must be identified and removed from circulation promptly to mitigate exposure risks.
Current Recommended Actions
Walgreens urges customers to discontinue use of any bottles belonging to the indicated lots. Unused products should be returned to the point of purchase for a full refund, a standard operating procedure in such health-related recalls. Consumers can find detailed recall information from the FDA’s official database.
Conclusion
In response to health concerns surrounding the contamination, the manufacturer Medical Products Laboratories, Inc. has coordinated efforts with Walgreens and other distributors for a smooth and comprehensive product withdrawal. Notably, no serious injuries or hospitalizations have been reported as of now in relation to this issue, but health authorities remain vigilant as the recall process continues. Consumers are encouraged to keep informed through the FDA’s reporting channels to check on recall statuses and batch information.
